Catalyst Wire Dossier Catalyst Wire Dossier

Invega Trinza

paliperidone palmitate · Janssen-Cilag Ltd
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Invega Trinza, covering 2015-06-18 to 2025-04-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Transition to the Paliperidone Palmitate 3-Month Formulation In Participants With Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month Formulation [Phase 3]

See pricing